ADVANCED COLORECTAL CARCINOMA
Clinical trials for ADVANCED COLORECTAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ADVANCED COLORECTAL CARCINOMA trials appear
Sign up with your email to follow new studies for ADVANCED COLORECTAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Epigenetic and immune drugs join forces against tough tumors
Disease control CompletedThis completed Phase 2 trial tested whether combining an immunotherapy drug (durvalumab) with an epigenetic drug (tazemetostat) can control advanced solid tumors like pancreatic, colorectal, and soft-tissue sarcoma. The study enrolled 164 adults and measured how well the combo sh…
Matched conditions: ADVANCED COLORECTAL CARCINOMA
Phase: PHASE2 • Sponsor: Institut Bergonié • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
New cocktail shows promise for Tough-to-Treat colorectal cancer
Disease control CompletedThis phase II trial tested a combination of three drugs—TAS-102, irinotecan, and bevacizumab—in 42 people with advanced colorectal cancer that had spread or couldn't be removed. The goal was to see if this mix could slow tumor growth better than standard treatments. Participants …
Matched conditions: ADVANCED COLORECTAL CARCINOMA
Phase: PHASE2 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC